IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today reported that U.S. prescription drug sales grew 5.4 percent to $251.8 billion in 2005, compared with $238.9 billion in sales the previous year.
